Reduced incidence of atrial fibrillation after cardiac surgery by continuous wireless monitoring of oxygen saturation on the normal ward and resultant oxygen therapy for hypoxia by Kisner, Dilek et al.
www.elsevier.com/locate/ejcts
cic Surgery 35 (2009) 111—115European Journal of Cardio-thoraReduced incidence of atrial fibrillation after cardiac surgery by
continuous wireless monitoring of oxygen saturation on the
normal ward and resultant oxygen therapy for hypoxia
Dilek Kisner a,*, Markus J. Wilhelm a, Michael S. Messerli a, Gregor Zu¨nd b, Michele Genoni a
aClinic for Cardiovascular Surgery, University Hospital Zurich, Ra¨mistr. 100, Zurich CH-8091, Switzerland
bDepartment of Experimental Surgery, University Hospital Zurich, Zurich, Switzerland
Received 8 May 2008; received in revised form 16 August 2008; accepted 18 August 2008; Available online 2 October 2008AbstractObjective: Monitoring of cardiac surgical patients after transfer from the intensive care unit to the normal ward is incomplete. Undetected
hypoxia, however, is known to be a risk factor for occurrence of atrial fibrillation. We have utilized AuricallW for continuous wireless monitoring of
oxygen saturation and heart rate until discharge. The object of the study was to analyze if oxygen therapy as a result of AuricallW alerts of hypoxia
can decrease the incidence of postoperative atrial fibrillation. Methods: AuricallW is a wireless portable pulse oximeter. An alert is generated
depending on preset threshold values (heart rate, oxygen saturation). Over a period of 6 months, 119 patients were monitored with the AuricallW
following coronary artery bypass graft and/or valve surgery. Oxygen therapy was started subsequent to an oxygen saturation below 90%. These
patients were compared with a cohort of 238 patients from the time period before availability of AuricallW. The patient characteristics were
comparable in both groups. In a retrospective study, the incidence of atrial fibrillation was measured in both groups. Results: The postoperative
AF was observed in 22/119 patients (18%) in group I and in 66/238 patients (28%) in group II. This difference between the two groups approached
significance ( p = 0.056). In the subgroup of patients with coronary artery bypass graft with our without simultaneous valve surgery (n = 312),
AuricallWmonitoring resulted in a significantly reduced incidence of atrial fibrillation (14% vs 26%, p = 0.016).Conclusions:Continuousmonitoring
of oxygen saturation on the normal ward and subsequent oxygen therapy for hypoxia can reduce the incidence of atrial fibrillation in a subgroup of
patients after cardiac surgery. Prospective randomized trials are warranted to confirm these data.
# 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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The optimal treatment of the hypoxemia after cardiac
surgery in the ward reduces the postoperative atrial
fibrillation. With the Auricall Monitoring System, you can
optimize the treatment, because the Auricall Monitoring
System is a reliable tool for continuous monitoring of the
oxygen saturation in the ward. Atrial fibrillation (AF), as the
most common arrhythmia after cardiac surgery (incidence,
20—45%) [1—7] and is associated with increased morbidity,
mortality, prolonged hospital stay, and increased costs [8,9].
Advanced age, hypoxemia and valvular heart operations are
the risk factors for this arrhythmia [10,11]. It usually has an
onset within 3—4 days postoperatively, and leads to
tachycardia, heart failure, and increased cerebrovascular
emboli as well as increased hospital stay and cost [12,13].
The incidence of AF after cardiac surgery is influenced by* Corresponding author. Tel.: +41 442551111.
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doi:10.1016/j.ejcts.2008.08.015various factors such as type of cardiac surgery, age of the
patient and preoperative treatment or withholding of beta-
blockers [1,3,4,7,13—16]. Age has been repeatedly shown to
be the major risk factor for atrial fibrillation after cardiac
surgery [1,3,14]. The persistently high incidence of this
complication over the past decades despite progress in
surgical techniques and anesthesia can be explained by the
increasing age of patients. Among the different types of
cardiac operations, the combination of coronary artery
bypass grafting (CABG) and valve procedures has the highest
incidence reaching 62% [4]. AuricallW is continuous monitor-
ing of oxygen saturation and allows immediate therapy. The
assumption that the incidence of postoperative atrial
fibrillation in the patient group that was monitored with
the AuricallW system is lower than in the unmonitored control
group was confirmed in this study. The reduction in the
incidence of postoperative AF achieved varied depending on
the type of operation. With the exception of one of the six
subgroups, the use of AuricallWwas associated with a reduced
incidence of AF in all groups. In all the incidence of AF was
reduced by 10%.Surgery. Published by Elsevier B.V. All rights reserved.
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Table 1
Patient characteristics
Group I n = 119/
357 (33%)
Group II n = 238/
357 (67%)
Time of observation October 2005—
April 2006
56/210 (27%)
Female 30/119 (25%) 60/238 (25%)
Male 89/119 (75%) 178/238 (75%)
Mean SD  age (years) 65.0  10.1 62.7  10.1
Range 39.2—86.2 32—86.4
OPCAB procedure 80/119 (67%) 160/238 (67%)
Valve replacement 15/19 (15%) 30/238 (13%)
NS, not significant; age (years, mean  SD) range.2. Materials and methods
2.1. AuricallW pulsoxymetry
Since October 2005 all patients have been monitored
with AuricallW postoperatively in the hospital’s normal
heart and vascular surgery ward. AuricallW is a monitoring
system manufactured by Cardiosafe International AG. The
central component of the system is a pulsoxymeter that
measures the oxygen saturation in the blood and the pulse
at the patient’s ear lobe. The doctor equips the patient
with one or more miniaturized sensors after the transfer
from ICU to the general floor. The Auricall sensors are
hardly noticed by the patient, either during the day or
when asleep. Monitoring is assured wherever there is
mobile network coverage; in the cafeteria, when walking
in the park, during physiotherapy or in the course of
activities outside the clinic. If there is no coverage, data
are recorded, saved and sent as soon as the connection is
re-established. As soon as a sensor registers a pathological
event, data transfer is started; as an alarm if immediate
response is called for, as a warning message otherwise. The
MD can specify the patient profile and the corresponding
triggering patterns. Data transfer takes place via mobile
phone technology and a secure Internet link. When an
alarm is triggered, the corresponding data will appear
instantaneously on a PC. At the same time a pager and/or
SMS message is sent to the treating doctor and to the
nurse. In this way the patient will receive help within the
shortest possible time. The patient receives oxygen
therapy with 4 l oxygen until the SaO2 is normal. Threshold
values can be set individually. Intelligent algorithms ensure
that artifacts are effectively filtered out and false alarms
prevented. The MD receives an electronic documentation
from the Auricall Monitoring System describing the incident
of the atrial fibrillation, and can form a comprehensive
picture of the situation as a basis for therapy definition. We
detected the atrial fibrillation also with the elective daily
ECG and from the documentation from the Auricall
Monitoring System. The episodes of the hypoxemia were
not followed by the atrial fibrillation. The system
described the incident of the atrial fibrillation. After the
appearance of atrial fibrillation, the patients have
continuous oxygen therapy until they leave the hospital.
The technical problems of the device were: defect in the
miniaturized sensors of the earlobe or patients forgetting
the device and leaving the room.
We had the approval of the ethics committee of the
University Hospital Zurich. We did not inform the patients
because the study was retrospective. The manufacture has
no financial interest of this study.
The main included factors in this study were, that the
patients were in sinus rhythm preoperative and we selected
the patients in two groups for age, sex and operation type.
There were 357 patients in total. A total of 119/357 patients
were monitored with Auricall Monitoring System in 6 months.
The main excluding factor was that the patients had atrial
fibrillation preoperatively. Patients with preoperative docu-
mented chronic or paroxysmal AF or who were taking
antiarrhythmic medications (e.g., amiodarone, sotalol) were
excluded.2.2. Patient characteristics
Between December 1984 and April 2006, 357 patients
were included in the study of all the other patients at the
University Hospital Zurich. We matched the patients for age,
sex, operation type and preoperative sinus rhythm. A total of
119/357 (33%) patients were monitored postoperatively with
the AuricallW pulsoxymeter on the normal ward between
October 2005 and April 2006 (group I). The comparison group
consisted of 238/357 (67%) patients who were treated before
the introduction of AuricallW. Their operation dates were
between December 1984 and September 2005 where only
about 7% of patients were operated on before 1999 (group II).
In order to ensure the best possible comparison between the
two groups we selected patients with similar characteristics
for the 238 people that made up the comparison group. In this
the highest priority was given to the operation type, followed
by the patient’s sex and age.
2.3. Statistical analyses
Statistical analysis was performed using SPSS, Version 10.1
(SPSS Inc, Chicago, IL). Age data are presented asmean (SD)
and compared between groups by using the Mann—Whitney U
test. The associations of all risk factors, operative data with
postoperative AF and differences in incidences between the
groups were analyzed using Pearson’s chi-square test. All p
values less than 0.05 were considered significant.3. Results
3.1. Patient characteristics
The patient characteristics are demonstrated in Table 1.
3.2. Incidence of atrial fibrillation
The postoperative AF was observed in 22/119 patients
(18%) in group I and in 66/238 patients (28%) in group II. This
difference between the two groups approached significance
( p = 0.056). The only significant point was the subgroup of
patients with coronary artery bypass graft with or without
simultaneous valve surgery (n = 312), AuricallW monitoring
resulted in a significantly reduced incidence of atrial
fibrillation (14% vs 26%, p = 0.016). The highest incidence
of AF occurred on the second postoperative day. This applied
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Table 2
The risk factors and rates of atrial fibrillation in group I (n = 119) and group II (n = 238)
Group I Group II
AF/n (%) p value AF/n p value
Sex Male 12/89 (13%) NS 48/178 (27%) NS
Female 10/30 (33%) 18/60 (30%)
Hypertension HT (+) 16/86 (19%) NS 46/148 (31%) NS
HT () 6/33 (18%) 20/90 (22%)
Nicotine N (+) 5/65 (64%) 0.001 33/119 (28) NS
N () 17/55 (31%) 33/119 (28%)
Obesity O (+) 5/39 (13%) NS 33/100 (33%) NS
O () 17/80 (21%) 33/138 (24%)
Hypercholesterinemia HC (+) 14/92 (15%) NS 37/153 (24%) NS
HC () 8/27(30%) 29/85 (34%)
Diabetes mellitus DM (+) 4/32 (13%) NS 12/48 (25%) NS
DM () 18/87(21%) 54/190 (28%)
Family history FH (+) 7/31 (23%) NS 27/86 (31%) NS
FH () 15/88 (17%) 39/152 (26%)
NS, not significant; age (years, mean  SD) range.for patients in group I as well as for group II. The first
occurrence of AF was 24—48 h postoperatively in 21/66 (32%)
patients in the group II and in 1/22 (5%) patients in group I.
The relationship between the preoperative risk factors and
occurrence of postoperative AF in group I and group II
outlined in Table 2. When considering sex as a risk factor,
there was not significant difference between the male (13%)
and female (33%) in group I. The significant difference was
not observed in group II. When considering hypertension as a
risk factor, there was not significant difference between
hypertensive and non-hypertensive patients in both groups.
Moreover, we determined that the rate of AF was significantly
higher in patient with nicotine history only in group I
( p = 0.001). The baseline operative data and rates of atrial
fibrillation are listed in Table 3. The incidence of post-
operative AF after valve surgery was not significant in both
groups. But there was a statistically significant difference
between two groups when considering the incidence of AF
after on-pump and off-pump myocardial revascularization.
The relationship between preoperative main disease and
occurrence of postoperative AF in group I and group II wereTable 3
The baseline operative data and rates of atrial fibrillation in group I (n = 119)
and group II (n = 238)
Patients (n) AF (n) AF (%) p value
Surgical data
CABG off-pump Group I 80 10 13 0.051
Group II 160 37 23
CABG on-pump Group I 11 1 9 NS
Group II 22 4 18
Valvular surgery only Group I 15 7 47 NS
Group II 30 11 37
CABG, combined with
valve surgery
Group I 13 4 31 NS
Group II 26 14 54
CABG, coronary artery bypass grafting; NS, not significant.summarized in Table 4. When considering valve disease,
there was a significant difference between valve stenosis/
insufficiency and non-valve stenosis/insufficiency in group II.
3.3. Oxygen saturation and therapy
If you look at group I that was monitored with AuricallW,
the average number of hypoxemic events in patients both
with and without postoperative AF was 4.6. Even the media
with 2 was the same in both groups. What is noticeable is that
with 35/97 patients (36%) with constantly recurring sinus
rhythm, not a single hypoxemic phase was recorded. In 2/22
patients (9%) with postoperative AF not a single hypoxemic
phase was recorded either. This difference is significant (chi-
square test: p = 0.014). If you compare patients with
constantly recurring sinus rhythm statistically with patients
with AF, you will note a significant difference in the number
of hypoxemic phases. The chi-square test gives a p value of
0.038.Table 4
The main disease and rates of atrial fibrillation in group I (n = 119) and group II
(n = 238)
Group I Group II
AF/n (%) p value AF/n (%) p value
Coronary artery
disease
(+) 15/105 (14%) 0.001 56/210 (27%) NS
() 7/14 (50%) 10/28 (36%)
Valve stenosis (+) 7/23 (30%) NS 22/44 (50%) <0.001
() 15/96 (16%) 44/194 (23%)
Valve insufficiency (+) 6/18 (33%) NS 22/54 (41%) 0.02
() 16/101 (16%) 44/184 (24%)
Acute myocardial
infarction
(+) 0/7 (0%) NS 1/7 (14%) NS
() 22/112 (20%) 65/231 (28%)
NS, not significant; age (years, mean  SD) range.
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We believe that the continuous monitoring of oxygen
saturation and the optimal therapy of the hypoxemia after
cardiac surgery lowered the incidence of AF. The incidence of
AF in the group monitored with AuricallW was 10% lower in all
than in the unmonitored patient group on the normal ward.
The postoperative AFwas observed in 18% of patients in group
I and in 28% of patients in group II. There was an approached
significant difference between the two groups when
considering the incidence of postoperative AF ( p = 0.056).
The only significant point was that with the subgroup of
patients with coronary artery bypass graft with or without
simultaneous valve surgery (n = 312), AuricallW monitoring
resulted in a significantly reduced incidence of atrial
fibrillation (14% vs 26%, p = 0.016). For this patient group
it follows consequently that the optimized oxygen treatment
can reduce the incidence of AF after heart surgery. In the
other subgroups no significant differences could be detected
between patients who were monitored postoperatively and
those who were not. The incidence of postoperative AF in the
monitored patient cohort in the Zurich University Hospital
was 25% in total and when differentiating between the
individual types of operation, between 15% (off-pump CABG)
and 46% (combined CABG and valve operations). Thus the
incidence determined was within the range of values known
from earlier studies. An American study in 1997 [17] relating
to a very comparable cohort showed an incidence of 30%. It
also describes a significantly increased incidence in opera-
tions on aortic andmitral valves andwith combined CABG and
valve operations. The incidence of AF that we detected with
just CABG operations (19%) can be seen alongside literature
values of 10% [18], 16% [19], and 18% [8]. The question of
whether the use of a heart-lung machine represents a risk
factor for postoperative AF is answered inconsistently in
studies. While some studies indicate a higher incidence after
operations with extracorporeal circulation [8,21], others
detect a higher incidence after off-pump operations [17,18].
In our study the incidence of AF in off-pump operations was
5% higher than with operations using the heart-lung machine
(20% compared with 15%). The incidence of AF associated
with older people that we detected was also described in the
literature [9—11]. We did not analyze the extracorporeal
circulation or aortic clamping time. The connection between
oxygen treatment and the occurrence of postoperative AF
has already been investigated by Ba¨cklund et al. in a study
published in 1998 [20]. For this, patients who had undergone
a thoracotomy (without heart surgery) were given (35%)
oxygenated air either up to the first or up to the third day
after the operation. No significant difference in the incidence
of AF could be detected. But the cohort studied by Ba¨cklund
et al. only included 24 patients. In our study we approached
significant difference in the incidence of postoperative AF in
patients with optimized oxygen treatment. We noted a
significant reduction in the incidence of AF in patients after
CABG operations with and without the heart-lung machine
and in patients with CABG operations with and without valve
operations. Only the results from the patient group with
valve operations did not agree with our hypothesis. With this
type of operation we noted an increased frequency of AF in
the group monitored with AuricallW. The incidence of AF wasgenerally very high in this group at 47% or 37%. With all the
other subgroups and with the whole cohort of patients
investigated we were able to show, as expected, a reduced
incidence of AF in patients who were treated from October
2005 and who thus used the AuricallW pulsoxymeter. A study
by Mooe et al. in 1996 [11] investigated the connection
between sleep associated respiratory disturbances and the
occurrence of AF after bypass surgery. It is based on the
assumption that hypoxemic phases can trigger arrhythmia
because of sympathetic activation and hemodynamic stress
[11]. In this study postoperative AF was detected in 26% of
patients. With patients who had CABG operations in our study
the frequency of postoperative AF was 19%. Mooe et al.
divided their patient cohort into two groups using the
desaturation index (ODI) and the apnea hypopnea index
(AHI). AF was diagnosed in 32% of patients with AHI > 5 and in
18% of patients with AHI < 5 ( p = 0.11). In patients with
ODI > 5 the incidence was 39%, in those with ODI<5 18%
( p = 0.02). The study by Mooe et al. also showed a
significantly longer stay in hospital and, just as in our study,
a significantly higher average age in patients with post-
operative AF than with patients without AF. A study by Gami
et al. [21] published in 2004 investigated the association of
AF and obstructive sleep apnea regardless of operations
undergone. One group of patients with AF was compared with
a group of patients with other cardiac diagnoses to
investigate the prevalence of obstructive sleep apnea. In
the group of patients with AF significantly more patients with
obstructive sleep apnea were noted than in the comparison
group (49% vs 32%). Thus almost half of patients with AF
suffered with obstructive sleep apnea syndrome. The study
[22] explains the increased risk of nicotine with AF. We
determined that the rate of AF was significantly higher in
patient with nicotine history only in the groupmonitoredwith
AuricallW ( p = 0.001). The study [21] explains the increased
risk of AF with obstructive sleep apnea syndrome because of a
hypoxia-related chain reaction that led to arrhythmia via
hypercapnia, reaction of chemoreceptors and an increased
level of sympathicotonus. In addition the change in
intrathoracal pressure that occurs when breathing against
obstructions in the upper respiratory passages was described
as the cause. This change leads, of course, to changes in the
capacities of the heart chambers that may trigger dis-
turbances in rhythm as a result of the expansion-dependent
ion channels being activated. In a study by Gami et al. [10]
the following risk factors for the occurrence of AF were
mentioned: age, male, hypertonia, coronary heart disease,
heart failure, smoking, diabetes mellitus, high BMI and
obstructive sleep apnea syndrome. In our study, arterial
hypertonia, adiposity and advanced age (significant) related
to the whole cohort were also accompanied by an increased
incidence of AF. Nicotine consumption and diabetes mellitus
were, on the other hand, associated with a reduced incidence
of postoperative AF. Patients with hypercholesterinemia in
the cohort investigated by us were affected significantly less
often by postoperative AF than patients with normal
cholesterol readings. Also interesting is the fact that in
the group with AuricallW monitoring and optimized oxygen
treatment, AF was diagnosed significantly less often in
patients with the nicotine risk factor than in those without
this risk factor.
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